Biocept, Inc.
BIOC
BIOC was delisted on the 24th of October, 2023.
25 hedge funds and large institutions have $304K invested in Biocept, Inc. in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 25 → 25 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
62% less capital invested
Capital invested by funds: $808K → $304K (-$504K)
67% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$26.7K |
| 2 |
Renaissance Technologies
New York
|
+$15.2K |
| 3 |
Jane Street
New York
|
+$12.3K |
| 4 |
E
Ergoteles
New York
|
+$10.6K |
| 5 |
Goldman Sachs
New York
|
+$5.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$328K |
| 2 |
CCM
Connective Capital Management
Palo Alto,
California
|
-$57.4K |
| 3 |
VF
Virtu Financial
New York
|
-$12K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$7.35K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
-$6K |
BIOC Hedge Fund Activity: Q1 2023 in Review
25 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Biocept, Inc. (BIOC) for Q1 2023, worth a combined $304K — down 62% from $808K a quarter earlier.
Fund positioning in BIOC was balanced in Q1 2023: 5 funds opened new positions, 5 closed out, 3 added to existing stakes and 9 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $26.7K. The largest seller was Vanguard Group, exiting entirely with an estimated $328K sold.
- 25 institutional investors held Biocept, Inc. (BIOC) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $304K of Biocept, Inc. stock for Q1 2023, down 62% quarter-over-quarter.
- 5 funds opened new Biocept, Inc. positions in Q1 2023 and 5 closed out, a net change of 0 holders.
- The largest Biocept, Inc. buyer in Q1 2023 was HRT Financial, an estimated $26.7K added.
- The largest Biocept, Inc. seller in Q1 2023 was Vanguard Group, an estimated $328K sold.
Based on aggregated 13F filings for Q1 2023.